These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14072940)

  • 1. PLASMA-FIBRINOGEN LEVELS IN CORONARY-ARTERY DISEASE.
    EASTHAM RD; MORGAN EH
    Lancet; 1963 Dec; 2(7319):1196-7. PubMed ID: 14072940
    [No Abstract]   [Full Text] [Related]  

  • 2. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    IAROSHEVSKII AIa; ZHAVORONKOVA EK
    Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441
    [No Abstract]   [Full Text] [Related]  

  • 3. [OUR EXPERIENCE WITH THE OWREN TEST].
    CASTRO CM; GROIS J; GRILLI H; DESOLDATI L
    Dia Med; 1963 Nov; 35():1854-9. PubMed ID: 14099799
    [No Abstract]   [Full Text] [Related]  

  • 4. [EXPERIENCE IN THE CLINICAL USE OF FIBRINOLYSIN].
    PANCHENKO VM; ANDREENKO GV
    Ter Arkh; 1964 Jan; 36():43-51. PubMed ID: 14149444
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications for anticoagulant therapy.
    Lyon AF; DeGraff AC
    Am Heart J; 1969 Jan; 77(1):132-6. PubMed ID: 5782840
    [No Abstract]   [Full Text] [Related]  

  • 6. [RAPID DIGITALIZATION AND MAINTENANCE WITH DESACETYL-LANATOSIDE C; CLINICAL OBSERVATIONS].
    MRLLONI GF; DODESINI G; MARANGONI E
    Minerva Med; 1963 Nov; 54():3560-78. PubMed ID: 14126387
    [No Abstract]   [Full Text] [Related]  

  • 7. [COAGULATION AND ANTICOAGULATION FACTORS IN THE BLOOD AND THEIR ALTERATION IN DISORDERS OF CORONARY CIRCULATION].
    JAROSCHEWSKI AJ; SHAWORONKOWA EK
    Z Gesamte Inn Med; 1963 Aug; 18():686-91. PubMed ID: 14085697
    [No Abstract]   [Full Text] [Related]  

  • 8. OFFICE MANAGEMENT OF THE ANTICOAGULATED PATIENT.
    UDALL JA
    Geriatrics; 1964 Jul; 19():505-10. PubMed ID: 14183246
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):21-37. PubMed ID: 3515557
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulants: a guide for practitioners.
    Kingdon HS
    Postgrad Med; 1973 Aug; 54(2):61-5. PubMed ID: 4124472
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged ambulant treatment with anticoagulants].
    RENSCHLER HE; HARTMANN F
    Dtsch Med Wochenschr; 1962 Nov; 87():2281-8. PubMed ID: 13981693
    [No Abstract]   [Full Text] [Related]  

  • 12. [CHANGES IN BLOOD COAGULATION IN ISCHEMIC CORONARY STATES DETERMINED BY THE HEPARIN TOLERANCE TEST].
    SVEHLA C; SVORCIK C; SLIZ K; SPANKOVA H; MLEJNKOVA M; BAMBASOVA Z
    Cas Lek Cesk; 1964 May; 103():597-600. PubMed ID: 14167009
    [No Abstract]   [Full Text] [Related]  

  • 13. [PROPAGATION OF THE USE OF ANTICOAGULANT THERAPY IN HUNGARY AND SOME CURRENT PROBLEMS].
    PALOS AL
    Orv Hetil; 1964 Nov; 105():2215-8. PubMed ID: 14232610
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ANTICOAGULANT THERAPY OF MYOCARDIAL INFARCT].
    PUGLIESE F; SILVESTRI G
    Minerva Cardioangiol; 1963 Dec; 11():804-7. PubMed ID: 14118231
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of coronary artery disease.
    PATEL KM
    East Afr Med J; 1963 Jun; 40():329-32. PubMed ID: 13941809
    [No Abstract]   [Full Text] [Related]  

  • 17. [COMPARATIVE EVALUATION OF THROMBOELASTOGRAPHIC DATA AND SOME BIOCHEMICAL INDICES IN MYOCARDIAL INFARCT AND STENOCARDIA PATIENTS DURING ANTICOAGULANT THERAPY].
    ROMASHOV VP
    Ter Arkh; 1964 Jun; 36():11-7. PubMed ID: 14226949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on fibrinolytic activity and fibrinogen in the blood in atherosclerosis of the coronary vessels, myocardial infarction and during seizures of stenocardia].
    KOZHEVNIKOVA TL
    Ter Arkh; 1961 Mar; 33():97-101. PubMed ID: 13753757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statistical and clinical study of the significance of fibrinogenemia in the course of myocardial infarct].
    Bosisio P; Lolli G
    Cardiol Prat; 1967 Feb; 18(1):9-19. PubMed ID: 5600978
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac diseases.
    Turner RW
    Clin Haematol; 1972 Oct; 1(3):595-617. PubMed ID: 4620464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.